Key regions: Australia, Brazil, United Kingdom, Europe, Canada
The demand for vaccines has been increasing globally, and the GCC region is no exception. The Other Vaccines market in GCC has been witnessing growth due to various factors.
Customer preferences: Customers in the GCC region have been showing an increasing interest in vaccines due to the rise in infectious diseases. The awareness of the importance of vaccination has also been increasing, leading to an increase in demand for vaccines.
Trends in the market: The Other Vaccines market in GCC has been growing at a steady pace due to the increasing demand for vaccines. The market has been witnessing a shift towards combination vaccines, which offer protection against multiple diseases. This trend has been driven by the need to reduce the number of injections required and increase patient compliance. The market has also been witnessing the introduction of new vaccines, which offer protection against emerging diseases.
Local special circumstances: The GCC region has been witnessing an increase in the prevalence of infectious diseases, which has been driving the demand for vaccines. The region has also been witnessing a rise in the number of expatriates, who are more likely to get vaccinated due to the requirements of their home countries. The governments in the region have been actively promoting vaccination programs, which has also been driving the demand for vaccines.
Underlying macroeconomic factors: The GCC region has been experiencing economic growth, which has led to an increase in healthcare spending. The governments in the region have been investing heavily in healthcare infrastructure, which has led to an increase in the availability of vaccines. The region has also been witnessing an increase in medical tourism, which has been driving the demand for vaccines.In conclusion, the Other Vaccines market in GCC has been witnessing growth due to the increasing demand for vaccines, the shift towards combination vaccines, the introduction of new vaccines, the rise in the prevalence of infectious diseases, the increase in the number of expatriates, the promotion of vaccination programs by governments, the economic growth, the investment in healthcare infrastructure, and the increase in medical tourism.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
